5% stakes

Arch Venture Fund XII

Institution

5% stake reports
5
5% stake stocks
4
Latest report
26/08/14

5% stake reports

Stock
Parabilis Medicines PBLS08/145.3%6,412,780 shFirst report
Seaport Therapeutics SPTX05/0611.9%6,294,951 shFirst report
Neumora Therapeutics NMRA04/0118.7%33,965,419 sh−2.0pp
Neumora Therapeutics NMRA25/10/2920.7%33,958,967 shNo earlier report
Prime Medicine PRME25/08/1110.4%18,587,036 shNo earlier report